Trial Profile
Phase 1 Clinical Trial of intra-thoracic administration of Zoredronic Acid in Subjects with Unresectable Malignant Pleural Mesothelioma
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 01 Feb 2019
Price :
$35
*
At a glance
- Drugs Zoledronic acid (Primary)
- Indications Malignant-mesothelioma
- Focus Adverse reactions
- 31 Jan 2019 Status changed from active, no longer recruiting to completed.
- 10 Dec 2018 According to UMIN, the anticipated date for data entry closure is 30/04/2019.
- 10 Dec 2018 Status changed from recruiting to active, no longer recruiting.